Cerebral Venous Thrombosis – Analysis of a Consecutive Series of 33 Patients

Czech version

Authors: D. Krajíčková ¹; M. Košťál ²; A. Krajina ³; L. Klzo ³; P. Ďulíček ²; M. Kubíková ¹
Authors‘ workplace: LF UK a FN v Hradci Králové Neurologická klinika ¹; LF UK a FN v Hradci Králové II. interní klinika ²; LF UK a FN v Hradci Králové Radiologická klinika ³
Published in: Cesk Slov Neurol N 2010; 73/106(4): 402-408
Category: Original Paper

Overview

Objective:
To investigate the risk factors for cerebral venous thrombosis, especially inherited thrombophilic states and the relationships between them, the extent of sinus thrombosis, and brain lesions, together with their overall influence on outcome. Thus the study is intended to record presenting clinical symptoms and their relations to the location of the thrombosis, to monitor the time and the extent of recanalization and to verify its relationship to clinical outcome. Material and methods: 33 patients were included (24 women), average age 37 (33 for the women), with diagnosis confirmed by magnetic resonance angiography (MRA). We thoroughly examined 32 patients for thrombophilias and 31 had MRA checks within 3–4 months. To monitor the possibility of incomplete recanalization, a subsequent MRA scan was planned for two years later. Clinical outcome was assessed after the modified Rankin scale (mRS) 3–4 months after diagnosis. Results: 56% of the patients had a high extent of sinus thrombosis. Isolated lateral sinus thrombosis appeared to be relatively benign. Hormonal contraception (75% of the females) was the most common predisposing factor. An inherited thrombophilic state was diagnosed in 7 (21%) patients. These were younger (average age 24), with greater extent of thrombosis (71% vs 56%), and more often had venous infarction (43% vs 33%), parenchymal hemorrhage (29% vs 21%) and worse clinical outcome. Neither venous infarction itself (33%) nor parenchymal haemorrhage (21%) influenced clinical outcome. Overall prognosis was good for 91% of the patients (30/33), with complete or nearly complete recovery – mRS < 2; only one patient had mRS 3. The single patient who died had generalized bronchogenic carcinoma. Clinical outcome was not influenced by the extent of recanalization (partial/complete recanalization 82%). Conclusion: Young people with undetected inherited thrombophilia represent the most at-risk group for cerebral venous thrombosis.

Key words:
cerebral venous thrombosis – thrombophilia – venous infarction – recanalization – clinical outcome

Sources

1. Bousser MG, Ferro JM. Cerebral venous thrombosis: an update. Lancet Neurol 2007; 6(2): 162–170.

2. Einhaüpl K, Bousser MG, de Bruijn SF, Ferro JM, Martinelli I, Masuhr F et al. EFNS guidelines on the treatment of cerebral venous and sinus thrombosis. Eur J Neurol 2006; 13(6): 553–559.

3. Biousse V, Tong F, Newman NJ. Cerebral venous thrombosis. Curr Treat Options Neurol 2003; 5(5): 409–420.

4. Strada L, Gandolfo C, Del Sette M. Cerebral sinus and venous thrombosis in a subject with thyrotoxicosis and MTHFR gene polymorphism. Neurol Sci 2008; 29(5): 343–345.

5. Yoshimura S, Ago T, Kitazono T, Yonekura T, Kumai Y, Kuroda J et al. Cerebral sinus thrombosis in a patient with Cushing´s syndrome. J Neurol Neurosurg Psychiatry 2004; 76: 1182–1183.

6. Košťál M, Dulíček P, Malý J, Krajíčková D. Cerebral venous thrombosis risk factors and incidence of JAK2 V617F mutation. J Tromb Haemost 2009; 7 (Suppl 2): 524.

7. De Stefano V, Fiorini A, Rossi E, Za T, Farina G, Chiusolo P et al. Incidence of the JAK21 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders. J Thromb Haemost 2007; 5(4): 708–714.

8. Ugo V, Le Gal G, Lecucq L, Mottier D, Oger E. Prevalence of the JAK2 V617F mutation is low among unselected patients with a first episode of unprovoked venous thromboembolism. J Thromb Haemost 2008; 6(1): 203–205.

9. Cantu C, Alonso E, Jara A, Martínez L, Ríos C, Fernández Mde L et al. Hyperhomocysteinemia, low folate and vitamin B12 concentrations, and methylene tetrahydrofolate reductase mutation in cerebral venous thrombosis. Stroke 2004; 35(8): 1790–1794.

10. Dentali F, Crowther MA, Ageno W. Thrombophilic abnormalities, oral contraceptives, and risk of cerebral vein thrombosis: a meta-analysis. Blood 2006; 107(7): 2766–2773.

11. Deschiens MA, Conard J, Horellou MH, Ameri A, Preter M, Chedru F et al. Coagulation studies, Factor V Leiden, and anticardiolipin antibodies in 40 cases of cerebral venous thrombosis. Stroke 1996; 27(10): 1724–1730.

12. Ferro JM, Canhão P, Stam J, Bousser MG, Barinagarrementeria F. ISCVT investigators. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 2004; 35(3): 664–670.

13. Procházka M, Procházka V, Lubušký M, Procházková J, Hrbáč T. Mozková žilní trombóza u uživatelek hormonální antikoncepce. Cesk Slov Neurol N 2007; 70/103(6): 678–684.

14. Rosendaal FR, Helmerhorst FM, Vandenbroucke JP. Oral contraceptives, hormone replacement therapy and thrombosis. Thromb Haemost 2001; 86(1): 112–123.

15. Masuhr F, Mehraein S, Einhäupl K. Cerebral venous and sinus thrombosis. J Neurol 2004; 251(1): 11–23.

16. Bansal BC, Gupta RR, Prakash C. Stroke during pregnancy and puerperium in young females below the age of 40 years as a result of cerebral/venous sinus thrombosis. Jpn Heart J 1980; 21(2): 171–183.

17. Cantú C, Barinagarrementaria F. Cerebral venous thrombosis associated with pregnancy and puerperium: review of 67 cases. Stroke 1993; 24(12): 1880–1884.

18. Khealani BA, Wasay M, Saadah M, Sultana E, Mustafa S, Khan FS et al. Cerebral venous thrombosis: a descriptive multicenter study of patients in Pakistan and Middle East. Stroke 2008; 39(10): 2707–2711.

19. Ferro JM, Canhão P, Bousser MG, Stam J, Barinagarrementeria F. ISCVT investigators. Cerebral vein and sinus thrombosis in elderly patients. Stroke 2005; 36(9): 1927–1932.

20. Damak M, Crassard I, Wolff W, Bousser MG. Isolated lateral sinus thrombosis: a series of 62 patients. Stroke 2009; 40(2): 476–481.

21. Ferro JM, Canhão P, Bousser MG, Stam J, Barinagarrementeria F. ISCVT investigators. Early seizures in cerebral vein and dural sinus thrombosis: risk factors and role of antiepileptics. Stroke 2008; 39(4): 1152–1158.

22. Zubkov AY, McBane RD, Brown RD, Rabinstein AA. Brain lesions in cerebral venous sinus thrombosis. Stroke 2009; 40(4): 1509–1511.

23. Leach JL, Fortuna RB, Jones BV, Gaskill-Shipley MF. Imaging of cerebral venous thrombosis: current techniques, spectrum of findings, and diagnostic pitfalls. Radiographics 2006; 26 (Suppl 1): S19–S43.

24. Bergui M, Bradac GB, Daniele D. Brain lesions due to cerebral venous thrombosis do not correlate with sinus involvement. Neuroradiology 1999; 41(6): 419–424.

25. Favrole P, Guichard JP, Crassard I. Diffusion-weighted imaging of intravascular clots in cerebral venous thrombosis. Stroke 2004; 35(1): 99–103.

26. Stolz E, Trittmacher S, Rahimi A, Gerriets T, Röttger C, Siekmann R et al. Influence of recanalization on outcome in dural sinus thrombosis: a prospective study. Stroke 2004; 35(2): 544–547.

27. Strupp M, Covi M, Seelos K, Dichgans M, Brandt T. Cerebral venous thrombosis: correlation between recanalization and clinical outcome: a long-term follow-up of 40 patients. J Neurol 2002; 249(8): 1123–1124.

28. Dentali F, Gianni M, Crowther MA, Ageno W. Natural history of cerebral vein thrombosis: a systematic review. Blood 2006; 108(4):1129–1134.

29. Ferro JM, Lopes MG, Rosas MJ, Ferro MA, Fontes J. Long-term prognosis of cerebral vein and dural sinus thrombosis. Results of the VENOPORT Study. Cerebrovasc Dis 2002; 13(4): 272–278.

30. Breteau G, Mounier-Vehier F, Godefroy O, Gauvrit JY, Mackowiak-Cordoliani MA, Girot M et al. Cerebral venous thrombosis 3-year clinical outcome in 55 consecutive patients. J Neurol 2003; 250(1): 29–35.

31. Stolz E, Rahimi A, Gerriets T, Kraus J, Kaps M. Cerebral venous thrombosis: an all or nothing disease? Prognostic factors and long-term outcome. Clin Neurol Neurosurg 2005; 107(2): 99–107.

32. Koopman K, Uyttenboogaart M, Vroomen PC, van der Meerb J, De Keyser J, Luijckx GJ. Development and validation of a predictive outcome score of cerebral venous thrombosis. J Neurol Sci 2009; 276(1–2): 66–68.

33. Mehraein S, Ortwein H, Busch M, Weih M, Einhäupl K, Masuhr F. Risk of recurrence of cerebral venous and sinus thrombosis during subsequent pregnancy and puerperium. J Neurol Neurosurg Psychiatry 2003; 74(6): 814–816.

34. Chrobok V, Pellant A, Ehler E, Pokorný K, Šimáková E, Mrklovský M et al. Trombóza esovitého splavu – současný pohled na diagnostiku a léčbu. Cesk Slov Neurol N 2007; 70/103(4): 424–428.

35. Borovanský L. Vena jugularis interna. In: Borovanský L et al (eds). Soustavná anatomie člověka, díl II. 5. vyd. Praha: Avicenum 1976: 683–691.

36. Girot M, Ferro JM, Canhão P, Stam J, Bousser MG, Barinagarrementeria F et al. ISCVT investigators. Predictors of outcome in patients with cerebral venous thrombosis and intracerebral hemorrhagie. Stroke 2007; 38(2): 337–342.

37. Bárta T. Otogenná sepsa a sinustrombóza na klinike v Bratislave 1946–1965. Česk Otolaryngol 1969; 18: 115–118.

38. Brosch E. Hnisavý zánět vnitřního ucha, hlíza mozečku a trombóza esovitého splavu jako komplikace vleklého zánětu středoušního. Česk Otolaryngol 1962; 11: 236–239.

39. Pellant A. Záněty ucha, nosu, vedlejších nosních dutin a nitrolebí a jejich vzájemné vztahy (habilitační práce). Hradec Králové: Lékařská fakulta UK 1995.

40. Mehraein S, Schmidtke K, Villringer A, Valdueza JM, Masuhr F. Heparin treatment in cerebral sinus and venous thrombosis: patients at risk of fatal outcome. Cerebrovasc Dis 2003; 15(1–2): 17–21.

41. de Bruijn SF, de Haan RJ, Stam J. For the Cerebral Venous Sinus Thrombosis Study Group. Clinical features and prognostic factors of cerebral venous sinus thrombosis in a prospective series of 59 patients. J Neurol Neurosurg Psychiatry 2001; 70(1): 105–108.

42. Cakmak S, Derex L, Berruyer M, Nighoghossian N, Philippeau F, Adeleine P et al. Cerebral venous thrombosis: clinical outcome and systematic screening of prothrombotic factors. Neurology 2003; 60(7): 1175–1178.

43. Bousser MG. Cerebral venous thrombosis: nothing, heparin, or local thrombolysis? Stroke 1999; 30(3): 481–483.

44. Fink JN, McAuley DL. Safety of anticoagulation for cerebral venous thrombosis associated with intracerebral hematoma. Neurology 2001; 57(6): 1138–1139.

45. Stam J, de Bruijn SF, deVeber G. Anticoagulation for cerebral sinus thrombosis. Stroke 2003; 34(4): 1054–1055.

46. Biousse V, Bousser MG. Cerebral venous thrombosis. Neurologist 1999; 57(5): 326–349.

47. Ciccone A, Canhão P, Falcão F, Ferro JM, Sterzi R. Thrombolysis for cerebral vein and dural sinus thrombosis. Cochrane Database Syst Rev 2004; 1: CD003693.

48. Krajina A, Krajíčková D, Náhlovský J. Endovaskulární rekanalizace akutní trombózy mozkových splavů. In: Krajina A, Peregrin JH et al (eds). Intervenční radiologie – Miniinvazivní terapie. 1. vyd. Hradec Králové: Aurius s.r.o. 2005: 397–404.

49. Röttger C, Madlener K, Heil M, Gerriets T, Walberer M, Wessels T et al. Is heparin treatment the optimal management for cerebral venous thrombosis? Effect of abciximab, recombinant tissue plasminogen activator, and enoxaparin in experimentally induced superior sagittal sinus thrombosis. Stroke 2005; 36(4): 841–846.

50. Canhão P, Falcão F, Ferro JM. Thrombolytics for cerebral sinus thrombosis: a systematic review. Cerebrovasc Dis 2003; 15(3): 159–166.

51. Stam J, Majoie CB, van Delden OM, van Lienden KP, Reekers JA. Endovascular thrombectomy and thrombolysis for severe cerebral sinus thrombosis: a prospective study. Stroke 2008; 39(5):1487–1490.

52. Countiho JM, Majoie CB, Coert BA, Stam J. Decompressive hemicraniectomy in cerebral sinus thrombosis: consecutive case series and review of the literature. Stroke 2009; 40(6): 2233–2235.

53. Keller E, Pangalu A, Fandino J, Könü D, Yonekawa Y. Decompressive craniectomy in severe cerebral venous and dural sinus thrombosis. Acta Neurochir Suppl 2005; 94: 177–183.

54. Countiho JM, Ferro JM, Canhão P, Barinagarrementaria F, Cantu C, Bousser MG et al. Cerebral venous and sinus thrombosis in women. Stroke 2009; 40(7): 2356–2361.